Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients

C Caldas; P Andrade; C Azevedo; C Pioeiro; R Serrao; J Soares; R Marques; A Sarmento

首页> 外文期刊>Journal of the International Aids Society >Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients

【24h】

Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients

机译：在葡萄牙艾滋病毒感染患者队列中开始抗逆转录病毒治疗后的第一年治疗中断原因

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the International Aids Society》 |2010年第4期|共页
作者
C Caldas; P Andrade; C Azevedo; C Pioeiro; R Serrao; J Soares; R Marques; A Sarmento;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patients. [J] . Hansel A, Bucher HC, Nuesch R, JAIDS: Journal of acquired immune deficiency syndromes . 2001,第2期

机译：一群未使用蛋白酶抑制剂的未感染HIV的患者中止首次高活性抗逆转录病毒治疗的原因。
2. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients. [J] . Cicconi P, Cozzi Lepri A, Castagna HIV medicine . 2010,第2期

机译：根据首次接受抗逆转录病毒治疗的患者队列中开始高活性抗逆转录病毒治疗的治疗方案的年份，了解终止治疗的原因。
3. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation [J] . Franco Maggiolo, Giorgio L Colombo, Sergio Di Matteo, Patient Related Outcome Measures . 2015,第1期

机译：一组HIV感染患者在6年的观察期间开始一线高活性抗逆转录病毒治疗的抗逆转录病毒疗法的成本效益分析
4. Effect of highly active antiretroviral therapy (HAART) on lipid abnormalities in HIV-infected patients [C] . Estari Mamidala 2011 international conference on medical information and bioengineering. . 2011

机译：高效抗逆转录病毒疗法（HAART）对HIV感染患者血脂异常的影响
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients [O] . C Caldas, P Andrade, C Azevedo, 2010

机译：葡萄牙感染艾滋病毒的一组患者在开始抗逆转录病毒治疗后第一年中止治疗的原因
7. Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients [O] . Caldas C, Andrade P, Azevedo C, 2010

机译：葡萄牙感染艾滋病毒的一组患者在开始抗逆转录病毒治疗后第一年中止治疗的原因

Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients

著录项

相似文献

相关主题

期刊订阅